Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Gee

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Grade and stage at presentation do not predict mortality in patients with bladder cancer who survive their diseaseEdward M Messing, Ralph Madeb, Changyong Feng, et al.
The Journal of Urology|March 12, 2003
Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experienceArlene O Siefker-Radtke, Jason Gee, Yu Shen, et al.
Physiotherapy Research International : the Journal for Researchers and Clinicians in Physical Therapy|November 22, 2019
Changes in standing stability with balance-based torso-weighting with cerebellar ataxia: A pilot studyGail L Widener, Nicole Conley, Sarah Whiteford, et al.
Cancer|October 10, 2006
Long-term outcome of hematuria home screening for bladder cancer in menEdward M Messing, Ralph Madeb, Terry Young, et al.
The Prostate|January 22, 2013
Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pinJason Gee, Howard Bailey, Kyungmann Kim, et al.
Investigative Ophthalmology & Visual Science|October 18, 2012
Induction of endoplasmic reticulum stress genes, BiP and chop, in genetic and environmental models of retinal degenerationHeike Kroeger, Carissa Messah, Kelly Ahern, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 20, 2014
Soy food frequency questionnaire does not correlate with baseline isoflavone levels in patients with bladder cancerJill M Kolesar, Marcia Pomplun, Tom Havighurst, et al.
Genes|February 21, 2017
MicroRNA Expression Profile Identifies High Grade, Non-Muscle-Invasive Bladder Tumors at Elevated Risk to Progress to an Invasive PhenotypeSara M Lenherr, Sheaumei Tsai, Brasil Silva Neto, et al.
The American Journal of Pathology|January 23, 2010
Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progressionStephanie Tseng-Rogenski, Jason Gee, Kathleen Woods Ignatoski, et al.
Science Translational Medicine|October 18, 2013
Tumor-specific activation of an EGFR-targeting probody enhances therapeutic indexLuc R Desnoyers, Olga Vasiljeva, Jennifer H Richardson, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Grade and stage at presentation do not predict mortality in patients with bladder cancer who survive their diseaseEdward M Messing, Ralph Madeb, Changyong Feng, et al.
The Journal of Urology|March 12, 2003
Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experienceArlene O Siefker-Radtke, Jason Gee, Yu Shen, et al.
Physiotherapy Research International : the Journal for Researchers and Clinicians in Physical Therapy|November 22, 2019
Changes in standing stability with balance-based torso-weighting with cerebellar ataxia: A pilot studyGail L Widener, Nicole Conley, Sarah Whiteford, et al.
Cancer|October 10, 2006
Long-term outcome of hematuria home screening for bladder cancer in menEdward M Messing, Ralph Madeb, Terry Young, et al.
The Prostate|January 22, 2013
Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pinJason Gee, Howard Bailey, Kyungmann Kim, et al.
Investigative Ophthalmology & Visual Science|October 18, 2012
Induction of endoplasmic reticulum stress genes, BiP and chop, in genetic and environmental models of retinal degenerationHeike Kroeger, Carissa Messah, Kelly Ahern, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 20, 2014
Soy food frequency questionnaire does not correlate with baseline isoflavone levels in patients with bladder cancerJill M Kolesar, Marcia Pomplun, Tom Havighurst, et al.
Genes|February 21, 2017
MicroRNA Expression Profile Identifies High Grade, Non-Muscle-Invasive Bladder Tumors at Elevated Risk to Progress to an Invasive PhenotypeSara M Lenherr, Sheaumei Tsai, Brasil Silva Neto, et al.
The American Journal of Pathology|January 23, 2010
Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progressionStephanie Tseng-Rogenski, Jason Gee, Kathleen Woods Ignatoski, et al.
Science Translational Medicine|October 18, 2013
Tumor-specific activation of an EGFR-targeting probody enhances therapeutic indexLuc R Desnoyers, Olga Vasiljeva, Jennifer H Richardson, et al.
Pageof 2